Public limited company · Anzegem · incorporated on 07/07/1987
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 88,6 k € | -82.3% | 501,1 k € | — | |||||||||||||||||
| Gross margin | -30,9 k € | -144.6% | 69,2 k € | -50.6% | 140,1 k € | +140.7% | 58,2 k € | +23.7% | 47,1 k € | +100.8% | 23,4 k € | +266.6% | -14,1 k € | -157.3% | 24,5 k € | +265.7% | 6,7 k € | -76.2% | 28,2 k € | -72.7% | 103,3 k € | +274.9% | -59,0 k € | -0.1% | -59,0 k € | +5.2% | -62,2 k € | -7.0% | -58,1 k € | -283.4% | -15,2 k € | +61.4% | -39,3 k € | -107.4% | 532,2 k € | |
| EBITDA | -33,7 k € | -149.7% | 67,8 k € | -43.7% | 120,4 k € | +112.2% | 56,7 k € | +57.6% | 36,0 k € | +66.5% | 21,6 k € | +226.3% | -17,1 k € | -251.6% | 11,3 k € | +1625.5% | -740,6 € | -103.9% | 19,2 k € | -79.3% | 92,6 k € | +243.4% | -64,5 k € | +13.4% | -74,6 k € | -5.9% | -70,4 k € | -9.7% | -64,1 k € | -119.2% | -29,3 k € | +29.4% | -41,4 k € | -119.4% | 213,2 k € | |
| Operating profit | -53,3 k € | -209.4% | 48,7 k € | -27.4% | 67,2 k € | +62.9% | 41,2 k € | +113.4% | 19,3 k € | +617.4% | 2,7 k € | +106.9% | -38,9 k € | -242.7% | -11,4 k € | +45.0% | -20,7 k € | -385.0% | -4,3 k € | -106.8% | 62,9 k € | +167.7% | -93,0 k € | +14.8% | -109,1 k € | +19.2% | -135,1 k € | -26.9% | -106,4 k € | -24.3% | -85,6 k € | +14.5% | -100,1 k € | -184.9% | 117,9 k € | |
| Profit/loss | 283,5 k € | +312.8% | 68,7 k € | -16.5% | 82,2 k € | -94.7% | 1,6 M € | +3170.2% | 47,7 k € | +241.9% | 13,9 k € | +147.7% | -29,2 k € | -292.3% | 15,2 k € | -67.8% | 47,2 k € | -35.2% | 72,8 k € | -8.0% | 79,1 k € | +219.4% | -66,3 k € | -142.3% | 156,6 k € | +156.4% | -277,6 k € | -1012.6% | 30,4 k € | +150.8% | -59,8 k € | -134.9% | 171,4 k € | +22.4% | 140,0 k € | |
| Equity | 3,7 M € | +8.4% | 3,4 M € | +2.1% | 3,3 M € | +2.5% | 3,2 M € | +93.5% | 1,7 M € | +17.9% | 1,4 M € | +1.0% | 1,4 M € | -2.0% | 1,4 M € | +1.1% | 1,4 M € | +3.5% | 1,4 M € | +5.6% | 1,3 M € | +6.5% | 1,2 M € | -5.2% | 1,3 M € | +13.9% | 1,1 M € | -19.8% | 1,4 M € | +2.2% | 1,4 M € | -4.2% | 1,4 M € | +13.6% | 1,3 M € | |
| Total assets | 3,7 M € | +7.5% | 3,4 M € | +2.3% | 3,4 M € | +4.0% | 3,2 M € | +93.5% | 1,7 M € | +17.7% | 1,4 M € | +0.7% | 1,4 M € | -2.3% | 1,4 M € | +0.4% | 1,4 M € | -2.6% | 1,5 M € | -28.5% | 2,1 M € | +54.4% | 1,3 M € | -5.1% | 1,4 M € | -12.4% | 1,6 M € | +6.7% | 1,5 M € | -2.1% | 1,5 M € | -4.0% | 1,6 M € | -4.2% | 1,7 M € | |
| Cash | 1,5 M € | +1105.4% | 127,6 k € | -40.1% | 212,9 k € | -89.3% | 2,0 M € | +347.3% | 444,2 k € | +95.5% | 227,2 k € | -29.9% | 323,9 k € | +20.6% | 268,5 k € | +51.4% | 177,4 k € | -20.4% | 222,8 k € | +1720.2% | 12,2 k € | -82.1% | 68,6 k € | +8.7% | 63,1 k € | -41.2% | 107,3 k € | -33.9% | 162,4 k € | +5830.0% | 2,7 k € | -97.5% | 108,7 k € | +981.5% | 10,1 k € | |
| Debts | 32,9 k € | -45.4% | 60,2 k € | +17.7% | 51,2 k € | +948.1% | 4,9 k € | +82.0% | 2,7 k € | -47.6% | 5,1 k € | -43.0% | 9,0 k € | -31.8% | 13,2 k € | +129.5% | 5,7 k € | -93.6% | 89,9 k € | -88.0% | 750,1 k € | +649.4% | 100,1 k € | +0.6% | 99,5 k € | -78.4% | 460,1 k € | +341.2% | 104,3 k € | -37.5% | 166,9 k € | -2.8% | 171,8 k € | -58.5% | 413,7 k € | |
| Staff | — | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 6,8 | ||||||||||||||||||
Public limited company profitable and well capitalised. Cash position rising (+1105.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
D.I. is a Public limited company incorporated in 1987. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Anzegem.
Key indicators
7-day free trial, no credit card required.